| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of ACTN3 mRNA | affects expression | 21346803
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ACTN3 mRNA | affects expression | 16483693
|
| C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of ACTN3 mRNA | decreases expression | 20458559
|
| C006780 |
bisphenol A |
bisphenol A results in increased expression of ACTN3 mRNA | increases expression | 18180321
|
| D017313 |
Fenretinide |
Fenretinide results in decreased expression of ACTN3 mRNA | decreases expression | 16467112
|
| C058346 |
N-(4-methoxyphenyl)retinamide |
N-(4-methoxyphenyl)retinamide results in decreased expression of ACTN3 mRNA | decreases expression | 16467112
|
| C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in decreased expression of ACTN3 mRNA | decreases expression | 17616710
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
4.34 | 7525203 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.95 | 18287403 |
| MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.96 | 11798837 19825857 |
| MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
4.96 | 10697514 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
3.95 | 16206674 |
| MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.14 | 11985600 |
| MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.61 | 16187019 |
| MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.56 | 17123778 |
| MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
2.56 | 16601279 |
| MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.63 | 11589617 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.51 | 15553829 14691202 16217749 15073043 11135700 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
3.51 | 17159502 16270382 |
| MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.38 | 17123778 |
| MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.32 | 19014326 |
| MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.38 | 12490120 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
3.24 | 16274795 |
| MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.78 | 14694615 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.87 | 16154183 |
| MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.85 | 20501625 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
2.85 | 17273769 |
| MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.41 | 15095906 |
| MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.51 | 12609071 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
1.89 | 10525206 |
| MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.40 | 15213294 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
2.69 | 21346803 |
| MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.91 | 12903497 |
| MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
4.91 | 15264214 15150132 16510608 15547733 16704527 15878914 15623463 15547721 16805852 |
| MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
3.57 | 15073043 |
| MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.59 | 16904648 |
| MESH:D005909 |
Glioblastoma |
|
Fenretinide |
4.06 | 16187019 |
| MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.46 | 16393666 |
| MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.95 | 15070760 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.08 | 17077332 12560223 |
| MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.70 | 16972261 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.63 | 14633726 |
| MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
4.04 | 19077051 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.17 | 16467208 16968895 17050201 19850784 20471514 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.38 | 15622746 16966277 9834237 15213294 12712474 12679006 17712046 19225113 17869043 11161223 15336539 16891316 17217047 16823087 15748426 17107899 16330433 11468182 12018890 16112521 16331271 19075265 17649720 19642359 19035177 |
| MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.68 | 16882451 |
| MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
6.49 | 16707609 |
| MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
2.42 | 14682389 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
2.89 | 20377131 |
| MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.56 | 15213294 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
1.87 | 11798837 19825857 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
3.73 | 10697514 |
| MESH:D008545 |
Melanoma |
|
Fenretinide |
2.86 | 16270382 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
4.53 | 16274795 |
| MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.29 | 19417148 11468182 15949261 19549372 14977855 |
| MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
5.12 | 18349030 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.28 | 16882451 16105982 |
| MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.29 | 16624393 |
| MESH:D009369 |
Neoplasms |
|
Fenretinide |
3.41 | 17353921 15958647 |
| MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.30 | 16427766 11399458 |
| MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.28 | 10525206 |
| MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
6.07 | 16303764 |
| MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
4.36 | 14694615 |
| MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.38 | 11985600 |
| MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
5.44 | 16624393 12452020 19769630 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
5.44 | 16133793 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.89 | 15580305 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
5.89 | 15580305 |
| MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.47 | 19927285 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.35 | 10548101 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.49 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.67 | 19131511 |
| MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.67 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.67 | 17024972 |
| MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.18 | 10548101 |
| MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.60 | 16303925 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.29 | 16646077 |
| MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
7.12 | 16467112 |
| MESH:D012878 |
Skin Neoplasms |
|
N-(4-methoxyphenyl)retinamide |
7.12 | 16467112 |
| MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.70 | 17007042 |
| MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.70 | 17575124 12958204 |
| MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.38 | 16045194 16684133 |
| MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.29 | 19014326 |
| MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.36 | 15213294 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.76 | 12973940 12845720 20435036 11780464 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
5.76 | 16720286 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
4.83 | 16154183 |
| MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.45 | 14652134 |